Labeler
Janssen Pharmaceuticals, Inc. NDC Codes
Janssen Pharmaceuticals, Inc. lists 63 finished drug products in the FDA NDC Directory under NDC labeler code 50458.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Xarelto, Topamax, Risperdal, Invega Sustenna, Risperdal M-Tab, Invokamet XR, Invega Trinza, Invokamet, Invega, Risperdal Consta, Concerta, Invega Hafyera, Ponvory, Invokana, Spravato
- Active ingredients
- Risperidone, Paliperidone palmitate, Canagliflozin, Metformin hydrochloride, Topiramate, Rivaroxaban, Paliperidone, Methylphenidate hydrochloride, Ponesimod, Esketamine hydrochloride, Mebendazole, Pentosan polysulfate sodium
- NDC labeler codes
- 50458
- Strengths
- Canagliflozin 50 mg/1; Metformin hydrochloride 500 mg/1; Metformin hydrochloride 1000 mg/1; Canagliflozin 150 mg/1; Risperidone 1 mg/1; Risperidone 2 mg/1; Risperidone 3 mg/1; Risperidone 4 mg/1; Risperidone .5 mg/1; Topiramate 25 mg/1; Risperidone 1 mg/mL; Rivaroxaban 155 mg/1; Paliperidone palmitate 1092 mg/3.5mL; Paliperidone palmitate 1560 mg/5mL; Ponesimod 20 mg/1; Esketamine hydrochloride 28 mg/.2mL; Rivaroxaban 2.5 mg/1; Mebendazole 500 mg/1; Paliperidone palmitate 273 mg/.88mL; Paliperidone palmitate 410 mg/1.32mL
- Dosage forms
- Tablet, Film coated, Tablet, Extended release, Injection, Suspension, Extended release, Kit, Injection, Tablet, Orally disintegrating, Tablet, Tablet, Film coated, Extended release, Tablet, Coated, Solution, Capsule, Coated pellets, Granule, For suspension, Tablet, Chewable, Capsule, Gelatin coated, Capsule
- Routes
- Oral, Intramuscular, Nasal
- Drug classes (FDA established)
- Atypical Antipsychotic, Sodium-Glucose Cotransporter 2 Inhibitor, Biguanide, Factor Xa Inhibitor, Central Nervous System Stimulant, Sphingosine 1-phosphate Receptor Modulator, Anthelmintic, Glycosaminoglycan, Azole Antifungal
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 89
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Xareltorivaroxaban | Rivaroxaban 155 mg/1 | Granule, For suspensionOral | 50458-575 | 50458-0575-01 | — |
| Invega Hafyerapaliperidone palmitate | Paliperidone palmitate 1092 mg/3.5mL | Injection, Suspension, Extended releaseIntramuscular | 50458-611 | 50458-0611-01 | — |
| Invega Hafyerapaliperidone palmitate | Paliperidone palmitate 1560 mg/5mL | Injection, Suspension, Extended releaseIntramuscular | 50458-612 | 50458-0612-01 | — |
| Ponvoryponesimod | — | Kit | 50458-707 | — | — |
| Ponvoryponesimod | Ponesimod 20 mg/1 | Tablet, Film coatedOral | 50458-720 | 50458-0720-30 | — |
| Spravatoesketamine hydrochloride | Esketamine hydrochloride 28 mg/.2mL | SolutionNasal | 50458-028 | 50458-0028-0250458-0028-03 | — |
| Xareltorivaroxaban | Rivaroxaban 2.5 mg/1 | Tablet, Film coatedOral | 50458-577 | 50458-0577-1050458-0577-1450458-0577-18+1 more | — |
| Vermoxmebendazole | Mebendazole 500 mg/1 | Tablet, ChewableOral | 50458-675 | 50458-0675-20 | — |
| Invokamet XRcanagliflozin and metformin hydrochloride | Canagliflozin 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | 50458-940 | 50458-0940-01 | — |
| Invokamet XRcanagliflozin and metformin hydrochloride | Canagliflozin 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 50458-941 | 50458-0941-01 | — |
| Invokamet XRcanagliflozin and metformin hydrochloride | Canagliflozin 150 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | 50458-942 | 50458-0942-01 | — |
| Invokamet XRcanagliflozin and metformin hydrochloride | Canagliflozin 150 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 50458-943 | 50458-0943-01 | — |
| Invega Trinzapaliperidone palmitate | Paliperidone palmitate 273 mg/.88mL | Injection, Suspension, Extended releaseIntramuscular | 50458-606 | 50458-0606-01 | — |
| Invega Trinzapaliperidone palmitate | Paliperidone palmitate 410 mg/1.32mL | Injection, Suspension, Extended releaseIntramuscular | 50458-607 | 50458-0607-01 | — |
| Invega Trinzapaliperidone palmitate | Paliperidone palmitate 546 mg/1.75mL | Injection, Suspension, Extended releaseIntramuscular | 50458-608 | 50458-0608-01 | — |
| Invega Trinzapaliperidone palmitate | Paliperidone palmitate 819 mg/2.63mL | Injection, Suspension, Extended releaseIntramuscular | 50458-609 | 50458-0609-01 | — |
| Xareltorivaroxaban | — | Kit | 50458-584 | 50458-0584-5150458-0584-52 | — |
| Invokametcanagliflozin and metformin hydrochloride | Canagliflozin 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | 50458-540 | 50458-0540-60 | — |
| Invokametcanagliflozin and metformin hydrochloride | Canagliflozin 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | 50458-541 | 50458-0541-60 | — |
| Invokametcanagliflozin and metformin hydrochloride | Canagliflozin 150 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | 50458-542 | 50458-0542-60 | — |
| Invokametcanagliflozin and metformin hydrochloride | Canagliflozin 150 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | 50458-543 | 50458-0543-60 | — |
| Invokanacanagliflozin | Canagliflozin 100 mg/1 | Tablet, Film coatedOral | 50458-140 | 50458-0140-0150458-0140-1050458-0140-30+2 more | — |
| Invokanacanagliflozin | Canagliflozin 300 mg/1 | Tablet, Film coatedOral | 50458-141 | 50458-0141-0150458-0141-1050458-0141-30+2 more | — |
| Xareltorivaroxaban | Rivaroxaban 20 mg/1 | Tablet, Film coatedOral | 50458-579 | 50458-0579-0750458-0579-1050458-0579-30+2 more | — |
| Xareltorivaroxaban | Rivaroxaban 15 mg/1 | Tablet, Film coatedOral | 50458-578 | 50458-0578-0750458-0578-1050458-0578-30+1 more | — |
| Xareltorivaroxaban | Rivaroxaban 10 mg/1 | Tablet, Film coatedOral | 50458-580 | 50458-0580-0750458-0580-1050458-0580-30+1 more | — |
| Invegapaliperidone | Paliperidone 1.5 mg/1 | Tablet, Extended releaseOral | 50458-554 | — | — |
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 39 mg/.25mL | InjectionIntramuscular | 50458-560 | 50458-0560-01 | — |
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 78 mg/.5mL | InjectionIntramuscular | 50458-561 | 50458-0561-01 | — |
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 117 mg/.75mL | InjectionIntramuscular | 50458-562 | 50458-0562-01 | — |
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 156 mg/mL | InjectionIntramuscular | 50458-563 | 50458-0563-0150458-0563-03 | — |
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 234 mg/1.5mL | InjectionIntramuscular | 50458-564 | 50458-0564-0150458-0564-03 | — |
| Invegapaliperidone | Paliperidone 3 mg/1 | Tablet, Extended releaseOral | 50458-550 | 50458-0550-0150458-0550-98 | — |
| Invegapaliperidone | Paliperidone 6 mg/1 | Tablet, Extended releaseOral | 50458-551 | 50458-0551-0150458-0551-98 | — |
| Invegapaliperidone | Paliperidone 9 mg/1 | Tablet, Extended releaseOral | 50458-552 | 50458-0552-0150458-0552-98 | — |
| Risperdal Constarisperidone | — | Kit | 50458-306 | 50458-0306-11 | — |
| Risperdal Constarisperidone | — | Kit | 50458-307 | 50458-0307-11 | — |
| Risperdal Constarisperidone | — | Kit | 50458-308 | 50458-0308-11 | — |
| Risperdal Constarisperidone | — | Kit | 50458-309 | 50458-0309-11 | — |
| Risperdal M-Tabrisperidone | Risperidone 1 mg/1 | Tablet, Orally disintegratingOral | 50458-315 | — | — |
| Risperdal M-Tabrisperidone | Risperidone 2 mg/1 | Tablet, Orally disintegratingOral | 50458-325 | — | — |
| Risperdal M-Tabrisperidone | Risperidone 3 mg/1 | Tablet, Orally disintegratingOral | 50458-335 | — | — |
| Risperdal M-Tabrisperidone | Risperidone 4 mg/1 | Tablet, Orally disintegratingOral | 50458-355 | — | — |
| Risperdal M-Tabrisperidone | Risperidone .5 mg/1 | Tablet, Orally disintegratingOral | 50458-395 | — | — |
| Concertamethylphenidate hydrochloride | Methylphenidate hydrochloride 18 mg/1 | Tablet, Extended releaseOral | 50458-585 | 50458-0585-01 | — |
| Concertamethylphenidate hydrochloride | Methylphenidate hydrochloride 36 mg/1 | Tablet, Extended releaseOral | 50458-586 | 50458-0586-01 | — |
| Concertamethylphenidate hydrochloride | Methylphenidate hydrochloride 54 mg/1 | Tablet, Extended releaseOral | 50458-587 | 50458-0587-01 | — |
| Concertamethylphenidate hydrochloride | Methylphenidate hydrochloride 27 mg/1 | Tablet, Extended releaseOral | 50458-588 | 50458-0588-01 | — |
| Topamaxtopiramate | Topiramate 25 mg/1 | Capsule, Coated pelletsOral | 50458-645 | 50458-0645-65 | — |
| Topamaxtopiramate | Topiramate 15 mg/1 | Capsule, Coated pelletsOral | 50458-647 | 50458-0647-65 | — |
Janssen Pharmaceuticals, Inc.: common questions
- What is Janssen Pharmaceuticals, Inc.'s NDC labeler code?
- 50458. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Janssen Pharmaceuticals, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.